Unlocking the Power of Tango Therapeutics: Exciting Inducement Grants Under NASDAQ Listing Rule Revealed!

Tango Therapeutics Announces Inducement Grants The Latest News from Tango Therapeutics BOSTON, March 06, 2023 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that, effective March 1, 2023, the Compensation Committee of Tango Therapeutics’ Board of Directors…

Read More

Muinmos Partners with DL Consulting for Enhanced Sales and Implementation Support in the Fintech Industry

The Impact of Muinmos’ Partnership with DL Consulting on Regtech Industry Partnership Overview Regtech firm Muinmos recently announced its partnership with Cyprus-based fintech services consultancy, DL Consulting, for sales and implementation support. This partnership is expected to help Muinmos strengthen its presence in Cyprus and expand its reach internationally. Muinmos Taps DL Consulting’s Services The…

Read More